Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Latvia

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,321 result(s) found for: Latvia. Displaying page 1 of 67.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2004-003340-22 Sponsor Protocol Number: A7501012 Start Date*: 2005-09-19
    Sponsor Name:Pfizer Luxembourg SARL Latvia Branch
    Full Title: A randomised, placebo controlled, double blind trial of asenapine in the prevention of relapse after long term treatment of schizophrenia.
    Medical condition: Schizophrenia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2005-002961-35 Sponsor Protocol Number: ILP.021.250/01L Start Date*: 2005-09-19
    Sponsor Name:AS "GRINDEKS"
    Full Title: MILDRONĀTA PIELIETOŠANAS EFEKTIVITĀTE UN DROŠĪBA SLIMNIEKIEM AR MIJKLIBOŠANU (CLAUDICATIO INTERMITTENS)
    Medical condition: PERIFĒRO ARTĒRIJU SLIMĪBA (PAS) AR MIJKLIBOŠANU (CLAUDICATIO INTERMITTENS) (II STADIJA PĒC FONTAINE)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2004-001154-86 Sponsor Protocol Number: 20020149 Start Date*: 2004-09-06
    Sponsor Name:Amgen Inc.
    Full Title: A Multicenter, Double-blind, Placebo-controlled Roll-over Study to Protocol 20010103 of Darbepoetin Alfa for the Treatment of Anemia of Cancer
    Medical condition: Anemia of cancer in subjects who are not receiving chemotherapy
    Disease: Version SOC Term Classification Code Term Level
    7.0 10049105 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2006-001487-23 Sponsor Protocol Number: TPU-SL-EU05-02 Start Date*: 2006-06-05
    Sponsor Name:Teikoku Pharma USA, Inc.
    Full Title: A Double Blind Randomized Controlled Study of the Effiacy and Safety of Topical Sterile 5% Lidocaine Patch in the Treatment of Postoperative Pain Due to Plastic Surgery of the Breast
    Medical condition: Postoperative Pain Due to the Plastic Surgery of the Breast
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: LV (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-000954-22 Sponsor Protocol Number: CI-1008-100 Start Date*: 2004-09-23
    Sponsor Name:Pfizer Global Research & Development
    Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders
    Medical condition: Generalized Anxiety Disorder
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2004-000773-60 Sponsor Protocol Number: SNMC 301 Start Date*: 2004-10-22
    Sponsor Name:Healthcare & Pharma Consulting AG (Europe)
    Full Title: 52 week multicenter, randomized, double-blind placebo-controlled trial evaluating the efficacy and safety of SNMC in patients with chronic hepatitis C
    Medical condition: Chronic hepatitis C
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001041-15 Sponsor Protocol Number: N3D/FOR-OCA-06 Start Date*: 2004-07-26
    Sponsor Name:Neuro3d
    Full Title: MULTICENTRE, DOUBLE-BLIND, RISING DOSE PARALLEL GROUP STUDY OF THE EFFICACY AND TOLERABILITY OF OCAPERIDONE VERSUS OLANZAPINE IN SCHIZOPHRENIC PATIENTS
    Medical condition: The populations of the study will be: -schizophrenic patients according to DSM IV-TR diagnosis -have to present the first symptoms of the schizophrenia for at least one year -have to present an exa...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005179-32 Sponsor Protocol Number: GRMSS-04-07 Start Date*: 2008-09-15
    Sponsor Name:Joint Stock Company "Grindeks"
    Full Title: Mildronate - Efficacy And Safety Of Treatment For Chronic Coronary Heart Disease (Stable Angina) I
    Medical condition: Chronic coronary heart disease (stable angina)
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2021-001400-16 Sponsor Protocol Number: 6-1/05/1 Start Date*: 2021-07-02
    Sponsor Name:Riga Stradins university
    Full Title: Investigation of pain syndrome and clinical-biochemical parameters in 7 to 18 years old children with acute uncomplicated appendicitis who received non-surgical treatment.
    Medical condition: Pain syndrome in 7 to 18 years old children with acute uncomplicated appendicitis, who received non-surgical treatment.
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: LV (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2018-004674-94 Sponsor Protocol Number: WI237607 Start Date*: 2019-04-05
    Sponsor Name:Riga Stradiņš University
    Full Title: Open-label Phase IV Study to Investigate Broad-and Cross-neutralizing Antibodies after Primary Vaccination with Two Different TBE Vaccines
    Medical condition: Active (prophylactic) immunization against tick-borne encephalitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10043847 Tick-borne viral encephalitis PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000955-40 Sponsor Protocol Number: CI-1008-152 Start Date*: 2004-09-23
    Sponsor Name:Pfizer Global Research & Development
    Full Title: A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder
    Medical condition: Generalized Anxiety Disorder
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2006-002738-39 Sponsor Protocol Number: 04-7-011 Start Date*: 2006-09-22
    Sponsor Name:Astelleas Pharma US, Inc.
    Full Title: A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (≥ 12 to ≤ 17 Years of Age ) with Psoriasis
    Medical condition: Determination of pharmacokinetics and safety of tacrolimus in adolescents with plaque psoriasis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10037153 Psoriasis LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2005-002735-27 Sponsor Protocol Number: R30-05-01 Start Date*: 2005-09-19
    Sponsor Name:Fidia Farmaceutici SpA
    Full Title: A multicentre study to assess the safety and efficacy of sodium hyaluronate (Hyalgan-F) produced by fermentation in knee psteoarthritis.
    Medical condition: Knee oasteoarthritis
    Disease:
    Population Age: Adults, Elderly Gender:
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2004-003776-10 Sponsor Protocol Number: N3D/FOR-OCA-08 Start Date*: 2004-10-22
    Sponsor Name:Neuro3d
    Full Title: Safety amd tolerability of ocaperidone in the continuation treatment of patients with schizophrenia: a double-blind, parallel group, multicentre, fixed dose, follow-up study
    Medical condition: The population of the study will be: - schizophrenic patients according to DSM IV-TR diagnosis - have to present the first symptoms of the schizophrenia for at least one year - have to present an e...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-003816-19 Sponsor Protocol Number: V4061 Start Date*: 2016-10-14
    Sponsor Name:ForSight VISION4, Inc
    Full Title: A Controlled Safety and Preliminary Efficacy Study of the V406 Port Delivery System in the Treatment of Choroidal Neovascularization Due toAge-Related Macular Degeneration
    Medical condition: Patients of either sex, 50 years of age or older, with a diagnosis of Choroidal Neovascularization CNV due to Age-Related Macular Degeneration AMD in the study eye
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-002481-31 Sponsor Protocol Number: IM011-011 Start Date*: 2017-02-02
    Sponsor Name:Bristol-Myers Squibb International Corporation
    Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis
    Medical condition: Moderate to Severe Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    19.1 10040785 - Skin and subcutaneous tissue disorders 10037153 Psoriasis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2005-003945-16 Sponsor Protocol Number: EGF105764 Start Date*: 2006-01-20
    Sponsor Name:GlaxoSmithKline R&D Ltd
    Full Title: An open-label, single-arm, multicentre, Phase II study of oral lapatinib in combination with paclitaxel as first-line treatment for ErbB2-amplified metastatic breast cancer patients
    Medical condition: Metastatic breast cancer
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2004-001611-58 Sponsor Protocol Number: GRMSS-03-06 Start Date*: 2005-05-10
    Sponsor Name:JSC Grindeks
    Full Title: Mildronate-efficacy and safety in treatment for chronic coronary heart disease (stable angina) - II
    Medical condition: Chronic coronary heart disease (stable angina)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2021-001729-38 Sponsor Protocol Number: 6-1/13/2020/31 Start Date*: 2021-07-02
    Sponsor Name:Arnis Eņģelis
    Full Title: Clinical and economical efficiency and safety and inflammation parameter correlations study of concervative treatment of non-complicated acute appendicitis in 7 to 18 years old children.
    Medical condition: Acute non-complicated appendicitis in patients aged 7 to 18
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: LV (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-005370-49 Sponsor Protocol Number: ML20601 Start Date*: 2006-12-13
    Sponsor Name:Roche Latvia
    Full Title: Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B
    Medical condition: HBeAg positive chronic Hepatitis B virus (ICD classification code: B18)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10008910 Chronic hepatitis B LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: EE (Completed) LT (Completed) LV (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 19:06:14 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA